12 - 14 May 2020
The Hotel Brussels,
Europe’s Leading Pharmaceutical Law Networking and Knowledge Hub
Make New Contacts, Meet Authority Experts and Discuss the Latest Legal Developments
Insights. Networking. Interactive Discussions.
EU Pharmaceutical Law: What's On?
Competition Law and Patent Litigation
Discover the latest insights from the EU Commission and cover everything from excessive pricing and killer acquisitions, to patent relief, arrow declarations and more...
Get to grips with the legislative status in the pharmaceutical industry. Including incentives and rewards, latest updates on orphan and paediatric medicines, transparent pricing, and legal considerations surrounding unapproved products.
Collaborations and Commercial Transactions
Identify the success factors for commercial collaborations, the key considerations for structuring deals, and the outlook towards commercialisation of data.
Healthcare Data, Privacy and Compliance
Refine your understanding of the legal challenges when managing GDPR for clinical research, ePrivacy, and digital patient support programmes, as well as the latest on anti-bribery and anti-corruption.
Continue your pharmaceutical legal learning
Join us at the evening seminars, designed to embed your knowledge and help you get the most out of your time at the conference.
Legal Strategies for Biosimilars
Tuesday 12 May
- Competition Issues for Biosimilars: Rebates and Lifecycle Management Strategies
- Intellectual Property Considerations for Biosimilars: Challenges and Opportunities
- Regulatory Frameworks for Biosimilars
EU MDR and IVDR for Pharmaceutical Firms
Wednesday 13 May
- New regulations and changes relevant to pharmaceutical companies
- Specifics for combination products, borderline products and companion diagnostic
Market Access for Innovative Therapies
Wednesday 13 May
- Value and pricing discussion
- Innovative payment models and structuring contracts
- Early Access Programmes
Who will you be rubbing shoulders with?
Meet the 'Who's Who' of European pharmaceutical law
Senior Director and General Counsel, Corporate & Transactions
Teva Pharmaceuticals Europe BV, The Netherlands
Get the latest event updates
State of the industry Report 2019
The pharmaceutical industry is facing an unprecedented level of disruption and the role of legal professionals in the industry is rapidly evolving to keep pace with
the changing needs of the businesses they support. Legal professionals sit at the axis of these changes, increasingly tasked with being strategic partners and business
enablers in the face of change. In March 2019, the EU Pharmaceutical Law Forum conducted a survey of legal professionals across Europe. Based on their responses, this report reveals unique
insights into the state of the industry in 2019; the hottest potential opportunities, the biggest challenges and how industry insiders are tackling them.
CONNECT WITH KEY BUYERS AT EU PHARMA LAW FORUM 2020 IN BRUSSELS
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Linda Cole: LCole@informaconnectls.com | +44 207 017 6631